Skip to content

Clinical trials

Completed Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Clear all

564 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20014
200211
200311
200412
200515
200618
200718
200825
200931
201021
201128
201227
201332
201420
201534
201632
201718
201820
201923
202032
202155
202224
202312
202411
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed564

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center35
National Cancer Institute (NCI)18
Fred Hutchinson Cancer Center14
Duke University11
Novartis Pharmaceuticals11
St. Jude Children's Research Hospital11
Dana-Farber Cancer Institute10
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University9
Celgene8
University of California, San Francisco8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms564
Multiple Myeloma75
Leukemia74
Lymphoma73
Leukemia, Myeloid, Acute70
Myelodysplastic Syndromes65
Neoplasms64
Precursor Cell Lymphoblastic Leukemia-Lymphoma56
Leukemia, Lymphocytic, Chronic, B-Cell45
Lymphoma, Non-Hodgkin44

Trials

Showing 1 to 25 of 564. Each trial links to its page on Pharma Observatory.

464 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.